Pharmacogenetics of inflammatory bowel disease.

Abstract excerpt

Pharmacogenetic studies have been performed for almost all classes of drugs that have been used in IBD but very few have generated consistent findings or have been replicated. The genetic test that has been approved for clinical practice is TPMT testing prior to starting treatment with thiopurine drugs. Research in IBD pharmacogenetics has focused on prediction of drug efficacy and toxicity by identifying...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adalimumab
• Share to Adrenal Cortex Hormones
• Share to Antibodies, Monoclonal, Humanized